JNJ - Johnson & Johnson
| Previous Close | 136.17 |
| Open | 133.31 |
| Bid | 127.71 x 1100 |
| Ask | 127.95 x 800 |
| Day's Range | 127.70 - 134.39 |
| 52 Week Range | 121.00 - 148.99 |
| Volume | 25,879,463 |
| Avg. Volume | 7,657,103 |
| Market Cap | 337.022B |
| Beta (3Y Monthly) | 0.73 |
| PE Ratio (TTM) | 19.99 |
| EPS (TTM) | 6.39 |
| Earnings Date | Jan 20, 2020 - Jan 24, 2020 |
| Forward Dividend & Yield | 3.80 (2.81%) |
| Ex-Dividend Date | 2019-08-26 |
| 1y Target Est | 150.19 |
- MarketWatch
Purdue Pharma creditors’ committee urges one mass settlement for all opioid lawsuits
A committee guiding OxyContin maker Purdue Pharma’s bankruptcy has suggested other drugmakers, distributors and pharmacy chains use Purdue’s bankruptcy proceedings to settle more than 2,000 lawsuits seeking to hold the drug industry accountable for the national opioid crisis.
- Market Exclusive
Market Weekend: Brexit Purgatory, Syria Troops to Iraq, J&J Arsenic, JPMorgan ‘Big Liquidity Thing’
Brexit Purgatory Continues As the world turns, so the Brexit saga continues. Futures traders are now betting the odds of first contact with an alien species of hyperintelligent snails is more likely than this chapter ever being closed. (This is not to be taken literally.) SEE: AMP Signs Cannabis Distribution Agreement with CC Pharma What happened […]The post Market Weekend: Brexit Purgatory, Syria Troops to Iraq, J&J Arsenic, JPMorgan ‘Big Liquidity Thing’ appeared first on Market Exclusive.
- Benzinga
Benzinga's Bulls And Bears Of The Week: Beyond Meat, Netflix, Johnson & Johnson And More
Benzinga has examined the prospects for many investor favorite stocks over the past week. Bullish calls included a second-tier telecom and a fast-casual restaurant leader. Bearish calls included beleaguered ...
- MarketWatch
Johnson & Johnson stock pummeled after asbestos-related baby powder recall
Shares of Johnson & Johnson suffers another blow Friday related to product safety, as the consumer products giant’s recall of some baby powder, after tests reveal traces of asbestos.
- Yahoo Finance
JNJ sheds light on why its settling some opioid cases instead of fighting in court
In this week’s Q3 earnings call, Johnson & Johnson's CFO shed some light on the company’s surprise decision to settle in Ohio.
- Barrons.com
5 Dividend Stocks With Safe and Growing Payouts When Bonds Can’t Do the Trick
Johnson & Johnson, Nucor, Illinois Tool Works, Pentair, and W.W. Grainger have kept their dividends intact and growing for years, making them solid investment considerations for a low-rate world
- GuruFocus.com
US Indexes Close Lower Friday After Weak China Data Report
S&P; 500 up 19.1% for the year Continue reading...
- Bloomberg
J&J Recalls Lot of Baby Powder After Asbestos Trace Found
(Bloomberg) -- Johnson & Johnson is recalling one lot of its Johnson’s Baby Powder after tiny amounts of asbestos contamination were found in samples from a single bottle purchased online.J&J is voluntarily recalling the lot, 22318RB, which consists of 33,000 bottles, and is encouraging people who bought the product to discontinue use. The company said that it is working with the Food and Drug Administration, which tested the bottle, and has started an investigation into how and when the product was contaminated.FDA spokeswoman Gloria Sanchez-Contreras said the contaminated bottle contained chrysotile fibers, a type of asbestos. The FDA recommended that consumers stop using the lot immediately and contact J&J for a refund. Another lot of Johnson’s Baby Powder the FDA tested was negative for asbestos, the agency said in a statement.J&J shares fell 6.2% to $127.70 at the close in New York, the biggest drop since December 2018. The stock has been under pressure as investors try to ascertain the company’s potential liabilities in a series of lawsuits related to talc and other products.“Thousands of tests over the past 40 years repeatedly confirm that our consumer talc products do not contain asbestos,” J&J said in a statement on Friday.J&J is looking into whether cross-contamination of the sample caused a false positive, whether the product was appropriately sealed and maintained in a controlled environment, and whether the product was a counterfeit. Sanchez-Contreras said the FDA “stands by the quality of its testing and results and is not aware of any adverse events relating to exposure to the lot of affected products.” The FDA has tested about 50 cosmetic products for asbestos since 2018 and plans to release the full results by the end of this year, the agency said.During a brief call with investors on Friday, J&J global supply chain and women’s health executives said they had received the product’s test results the previous day and acted promptly to inform the public. The investigation could take 30 days or more, they said. The executives didn’t take questions from participants on the call.Legal ImplicationsChief Financial Officer Joseph Wolk said on a Tuesday conference call with investors that the company wouldn’t set aside any legal reserves for the more than 100,000 lawsuits it faces across its portfolio of drugs, consumer products and medical devices, saying it expects to fight and win many of the claims.“The management team here will look at what a reasonable outcome could be for all stakeholders involved,” Wolk said. “When products are safe, when they’re effective, we’re going to look to make sure that those products aren’t subject to what’s become unfortunately a big business model for plaintiff’s attorneys.”J&J has already settled some of the lawsuits in which plaintiffs claim they were given cancer by the talc-based personal care products, but 15,500 suits remain, according to a July filing with the U.S. Securities and Exchange Commission.Company spokesman Ernie Knewitz declined to comment on the contamination beyond the news release and said he wouldn’t speculate on what the development means for the litigation.Baby Powder-related liabilities could eventually cost the company as much as $10 billion, according to Bloomberg Intelligence. Though the product accounts for only a small fraction of J&J’s annual revenue, it’s been a core brand for the company for more than a century.Longstanding ClaimsLawyers for women who blame their cancers on asbestos-tainted talc powder contend internal J&J documents indicated officials knew since the 1970s that powder mined in places such as Vermont and Italy contained trace amounts of asbestos, but failed to alert consumers or regulators. Asbestos is often found intertwined with talc.“Had J&J acted responsibly and removed Johnson’s Baby Powder from the market in the 1970s, they would have saved the lives of thousands of women who have died needlessly of ovarian cancer,” Leigh O’Dell, an Alabama lawyer who is leading the plaintiffs’ cases that have been consolidated before a federal judge in New Jersey for pretrial information exchanges, said on Friday.Mark Lanier, who persuaded a St. Louis jury last year to hit J&J with a $4.7 billion verdict on behalf of more than 20 women who said they developed ovarian cancer through long-term use of the company’s talc-based products, said he doesn’t expect this to be the last time that its talc will be found to contain asbestos.“This confirms thousands of tests” over the years that have uncovered asbestos in J&J’s Baby Powder, he said.Given that J&J’s lawyers made public statements this month that the company’s talc-based products were free of asbestos, the recall couldn’t come at worse time, said Nora Engstrom, a Stanford University law professor. The company has vowed for years that extensive testing showed no traces of asbestos, she noted.“The wisdom of J&J’s broad defense strategy for these talc cases clearly is now in doubt,” Engstrom said.J&J has refuted and, in many cases, appealed verdicts against it, citing conflicting evidence on whether talcum powder can cause cancer. In a statement provided to Time magazine after a new study’s publication, the company maintained that Baby Powder is safe.“We sympathize with anyone suffering from cancer, and we understand patients and their families are seeking answers. The facts are clear — Johnson’s Baby Powder is safe, does not contain asbestos nor does it cause cancer, as reflected in more than 40 years of scientific evidence,” the statement reads.J&J said in February that it had received subpoenas and inquiries related to its iconic baby-powder products from the U.S. Justice Department, the SEC and the top Democrat on the Senate Committee on Health, Education, Labor and Pensions. Knewitz, the J&J spokesman, said at the time the company would cooperate with the inquiries.Bloomberg News reported in July that the Justice Department is pursuing a criminal investigation into whether J&J lied to the public about the possible cancer risks of its talc powder.(Updates with FDA testing in third paragraph)To contact the reporters on this story: Riley Griffin in New York at rgriffin42@bloomberg.net;Jef Feeley in Wilmington, Delaware at jfeeley@bloomberg.netTo contact the editors responsible for this story: Crayton Harrison at tharrison5@bloomberg.net, Timothy Annett, Mark SchoifetFor more articles like this, please visit us at bloomberg.com©2019 Bloomberg L.P.
- Investing.com
Stocks - S&P Knocked Down by Boeing, JNJ, China
Investing.com – Stocks finished the week on a down note on slumps in Boeing and Johnson & Johnson, plus new worries about Chinese economic growth.
- Market Realist
Boeing and JNJ Drag Dow Lower, End Week in Red
The Dow Jones Industrial Average Index lost close to 260 points or 0.95% today. Boeing stock (BA) fell 6.73%, the biggest loss in the Dow today.
- Investor's Business Daily
J&J Stock Plunges After FDA Test Finds Asbestos In Baby Powder
Johnson & Johnson is voluntarily recalling one lot of its baby powder after Food and Drug Administration testing detected very low levels of asbestos in a single bottle. JNJ stock plunged.
- Investor's Business Daily
J&J Recalls Baby Powder After Asbestos Find — Is JNJ Stock A Safe Buy?
JNJ stock is forming a flat base. But several lawsuits claiming Johnson & Johnson baby powder caused cancer are weighing on shares. So, is the Dow Jones component a buy right now?
- Reuters
US STOCKS-Boeing, J&J, dismal China data drag Wall Street lower
Boeing Co and Johnson & Johnson shares led both the S&P 500's and the Dow's declines. Today's market weakness "has to do with (GDP) news out of China, Boeing and Johnson & Johnson," Cardillo added, saying "market sentiment in terms of earnings is positive."
- InvestorPlace
5 Top Stock Trades for Monday: BA, MSFT, JNJ, SNAP, AXP
Friday featured some volatility, a few earnings reports, and a selloff in several blue-chip and high-growth stocks. Here's a look at some top stock trades for next week. Top Stock Trades for Tomorrow No. 1: Boeing (BA)Shares of Boeing (NYSE:BA) were hammered on Friday as worries heat up over the 737 MAX once again. It sent the stock nosediving through $360 support, as well as all of its major moving averages.InvestorPlace - Stock Market News, Stock Advice & Trading TipsShould BA fail to hold the 38.2% retracement now, more losses could be on the way.Let's see how it handles this area now. Falling further could send it into the $320's. Above could send shares back to the $358-to-$365 area.Honestly, BA stock is a bit too volatile and news-driven for me at the moment. Top Stock Trades for Tomorrow No. 2: Microsoft (MSFT)Microsoft (NASDAQ:MSFT) will report earnings next week, and has been giving investors a little shake-and-bake in the days ahead. * 7 Software Stocks to Buy for Growth Shares nearly broke out just a few days ago. Yet on Friday, the stock momentarily crashed through the 50-day moving average. Below the 50-day could cause a further decline into the report -- which would seem to increase the odds of a post-earnings pop afterwards.Either way, should MSFT rally before or after earnings, see if it can push through resistance around $141. Below the 50-day and 100-day moving averages, could put the $130 to $131 level on the table, where it will also find the 78.6% retracement. Top Stock Trades for Tomorrow No. 3: Johnson & Johnson (JNJ)Man, Johnson & Johnson (NYSE:JNJ) just keeps shooting itself in the foot.Shares had been range-bound between $126.50 and $132.50 for months. After a beat-and-raise quarter earlier this week, shares were finally breaking out of this range.Then on Friday, the company announced a recall out of "an abundance of caution." The move sent J&J tumbling lower, and it is now back in its prior range. So long as range support holds, bulls can stay long JNJ.Below that level makes J&J susceptible to more losses, though. Top Stock Trades for Tomorrow No. 4: American Express (AXP)A top- and bottom-line earnings beat wasn't enough to jumpstart American Express (NYSE:AXP) stock on Friday.While the stock has finally broken out of that nasty downward channel (blue lines), it's failing to reclaim the 78.6% retracement and hold above the 50-day moving average.Keep it simple.Back below prior channel resistance, and the 200-day moving average and 61.8% retracement will likely be tested. Below $112.50 support is bearish. Above the 78.6% retracement and 100-day moving average at $120.85 is bullish. Top Stock Trades for Tomorrow No. 5: Snap (SNAP)Even an upgrade can't snap Snap (NYSE:SNAP) out of its latest funk, (apologies on the lame pun).Should shares lose the $13.50 level and fall below the 61.8% retracement near $13.25, a test of the 200-day moving average could be on the way. If they hold as support, investors need to see SNAP break out over channel resistance and reclaim the 20-day moving average.It wasn't that long ago that this name was on fire, but it has been a total dud over the last three to four weeks. Until it shows signs of turning it around, be careful on the long side.Bret Kenwell is the manager and author of Future Blue Chips and is on Twitter @BretKenwell. As of this writing, Bret Kenwell did not hold a position in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Reasons to Buy Canopy Growth Stock * 7 Restaurant Stocks to Leave on Your Plate * 4 Turnaround Plays to Buy Now The post 5 Top Stock Trades for Monday: BA, MSFT, JNJ, SNAP, AXP appeared first on InvestorPlace.
- TheStreet.com
[video]Game Plan for Earnings: Cramer's 'Mad Money' Recap (Friday 10/18/19)
Trade deal worries and earnings uncertainty will probably keep stocks under pressure. Here's Jim Cramer's game plan for next week.
- American City Business Journals
Johnson & Johnson recalls baby powder, the subject of a $4.7 billion St. Louis verdict
Johnson & Johnson stock plummeted Friday after the company recalled some baby powder, which has been the subject of billions of dollars in lawsuit losses in St. Louis and elsewhere.
- Investor's Business Daily
Bad Day On Stock Market Continues; These Two Stocks Took Down The Dow
The stock market sold off late Friday as economic worries eclipsed good news about corporate earnings. Dow stocks were especially hard hit.
- MarketWatch
Boeing, Johnson & Johnson share losses lead Dow's 200-point drop
DOW UPDATE The Dow Jones Industrial Average is falling Friday afternoon with shares of Boeing and Johnson & Johnson delivering the stiffest headwinds for the blue-chip average. Shares of Boeing (BA) and Johnson & Johnson (JNJ) have contributed to the index's intraday decline, as the Dow (DJIA) was most recently trading 206 points, or 0.
- Reuters
US STOCKS-Wall Street weighed by Boeing, J&J, bleak China data
Boeing Co and Johnson & Johnson shares led the blue-chip Dow's decline. Third-quarter earnings season has hit full stride, with 73 companies in the S&P 500 having reported.
- ETF Trends
U.S. Stock ETFs Falter on Global Growth Fears
U.S. markets and stock ETFs retreated Friday, stumbling after a strong week, on concerns over global growth in response to poor data out of China. On Friday, the Invesco QQQ Trust (NASDAQ: QQQ) was down ...
- Reuters
FDA alerts consumers of J&J baby powder recall, says it stands by tests
The U.S. Food & Drug Administration said on Friday that it found that a sample from one lot of Johnson & Johnson's baby powder contained chrysotile fibers, a type of asbestos, confirming test results the company disclosed earlier on Friday. In an emailed statement, the FDA said that it stands by the quality of its testing and results, and that it is not aware of any adverse events relating to exposure to the lot of affected product, but advised consumers to stop using powder from that batch.
- MarketWatch
Boeing's stock selloff a triple-digit point drag on the Dow
Boeing Co. is by far the biggest drag on the Dow Jones Industrial Average on Friday, as the aerospace giant's stock selloff accounts for a triple-digit decline all by itself. Takeaway Boeing and Johnson & Johnson's tumbled, and the Dow would actually be higher. Boeing's stock fell 4.8% in afternoon trading after Reuters reported that the company misled the Federal Aviation Administration regarding the safety of its 737 Max planes, which have been grounded since March after two deadly crashes. The $17.86-price decline was shaving about 121 points off the Dow's price. Meanwhile, J&J's stock dropped $7.83, or 5.8%, after the company announced an asbestos-related recall of its baby powder, to undercut the Dow by 53 points. With the Dow down 168 points, excluding the shares of Boeing and J&J would turn the Dow slightly positive.
- Yahoo Finance Video
Wells Fargo's 2019 retirement survey points out savings trends
Yahoo Finance's Scott Gamm joins YFi PM to discuss the savings trends indicated by Wells Fargo's 2019 retirement survey.
